News

2021/03/18

Regarding the SARS-CoV-2 antibody system that jointly developed by OMR, Euglena and Leave a Nest, Euglena has launched a service for medical institutions 

Regarding the SARS-CoV-2 antibody system that jointly developed by Order-made Medical Research Inc.(President: Yasufumi Murakami), Euglena Co., Ltd. (President: Mitsuru Izumo) and Leave a Nest Co., Ltd. (CTO: Joe Inoue), Euglena has launched a service for medical institutions.

For details, please see the press release from Euglena Co., Ltd.

https://www.euglena.jp/news/20201020-2/